x
Breaking News
More () »

Chandler-based Insys Therapeutics unit pleads guilty to opioid bribery scheme

A unit of the Chandler-based Insys Therapeutics pleaded guilty to fraud charges in an opioid bribery case.

BOSTON — A Chandler-based drug company subsidiary has pleaded guilty to fraud charges stemming from allegations that the manufacturer schemed to bribe doctors to prescribe its highly addictive fentanyl spray.

The guilty plea entered in Boston federal court Friday by Insys Therapeutics' operating unit is part of a settlement announced this week to resolve investigations into the company.

Insys Therapeutics has also agreed to pay $225 million.

PREVIOUSLY: Opioid maker agrees to pay $225M to settle federal probes

Insys Founder John Kapoor and four other former executives were convicted last month of running the bribery scheme. They filed court documents this week challenging their convictions.

RELATED: Founder of Chandler drug maker indicted in US-wide opioid conspiracy

Kapoor's attorneys say the former employees who testified against him weren't credible.

His lawyers say prosecutors also introduced unfair and irrelevant evidence, including a rap video showing sales representatives dancing around a person dressed as a bottle of the opioid.

Before You Leave, Check This Out